These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28524157)

  • 1. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
    Benton SC; Butler P; Allen K; Chesters M; Rickard S; Stanley S; Roope R; Vulkan D; Duffy SW
    Br J Cancer; 2017 Jun; 116(12):1551-1557. PubMed ID: 28524157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
    von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
    BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
    Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
    Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
    Raine R; Duffy SW; Wardle J; Solmi F; Morris S; Howe R; Kralj-Hans I; Snowball J; Counsell N; Moss S; Hackshaw A; von Wagner C; Vart G; McGregor LM; Smith SG; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Atkin W
    Br J Cancer; 2016 Feb; 114(3):321-6. PubMed ID: 26742011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
    Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
    Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population.
    Kaushal A; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Duffy S; von Wagner C
    Prev Med; 2020 Dec; 141():106268. PubMed ID: 33022321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial.
    Hirst Y; Skrobanski H; Kerrison RS; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
    Br J Cancer; 2017 May; 116(11):1408-1414. PubMed ID: 28441381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
    Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
    BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using primary care-based paper and telephone interventions to increase uptake of bowel scope screening in Yorkshire: a protocol of a randomised controlled trial.
    McGregor LM; Kerrison RS; Green T; Macleod U; Hughes M; Gibbins M; Morris S; Rees C; von Wagner C
    BMJ Open; 2018 Jul; 8(7):e024616. PubMed ID: 30056395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
    Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
    Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening.
    Steele RJ; Kostourou I; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser C
    BMJ; 2010 Oct; 341():c5531. PubMed ID: 20980376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner.
    Cole SR; Young GP; Byrne D; Guy JR; Morcom J
    J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.
    Raine R; Moss SM; von Wagner C; Atkin W; Hans IK; Howe R; Solmi F; Morris S; Counsell N; Hackshaw A; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Snowball J; Seaman H; Thomas M; Smith SG; McGregor LM; Vart G; Wardle J; Duffy SW
    Br J Cancer; 2016 Dec; 115(12):1479-1486. PubMed ID: 27875518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A telephone reminder intervention to improve breast screening information and access.
    Offman J; Myles J; Ariyanayagam S; Colorado Z; Sharp M; Cruice M; North BV; Shiel S; Baker T; Jefferies R; Binysh K; Duffy SW
    Public Health; 2014 Nov; 128(11):1017-22. PubMed ID: 25443131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mailed Letter Versus Phone Call to Increase Uptake of Cancer Screening: A Pragmatic, Randomized Trial.
    Kiran T; Davie S; Moineddin R; Lofters A
    J Am Board Fam Med; 2018; 31(6):857-868. PubMed ID: 30413542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving uptake of flexible sigmoidoscopy screening: a randomized trial of nonparticipant reminders in the English Screening Programme.
    Kerrison RS; McGregor LM; Marshall S; Isitt J; Counsell N; Rees CJ; von Wagner C
    Endoscopy; 2017 Jan; 49(1):35-43. PubMed ID: 27997965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.